Instil Bio, Inc.
TIL· Nasdaq
Released Mar 4, 2025, before the open
10-K filed Mar 4, 2025, 63 days after period end · 0001789769-25-000017
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | — | — | $0.00 |
| Net Income | -$11.90M |
Instil Bio, Inc. · CIK 1789769 · Engraved from SEC EDGAR
| -$12.93M |
| -$53.84M |
| -$55.35M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.